DRD2 and Parkinson disease: For instance, antagonism orpartial agonism of D2R has been demonstrated to worsenParkinsonism, while action at D1R in conjunction with levodopaadministration is associated with increased LID severity.60−64 Therefore, the pursuit of D4R antagonists for PD therapydemands meticulous attention to the selectivity and efficacy of thedesigned compounds.